X0609 4 2026-05-27 0 0001706431 Vir Biotechnology, Inc. VIR 0001207792 MORE ROBERT J false C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 1 0 0 0 0 Common Stock 2026-05-27 4 A 0 8000 0 A 48656 D Common Stock 509917 I See footnote Stock Option (Right to Buy) 9.10 2026-05-27 4 A 0 16000 0 A 2027-05-27 2036-05-26 Common Stock 16000 16000 D Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. The RSUs will vest in full on May 27, 2027. Shares held by the Reporting Person for the benefit of Alta Partners NextGen Fund I, L.P. (APNG 1) were transferred by the Reporting Person for no consideration to APNG 1 in connection with the vesting of RSU awards. The Reporting Person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the Reporting Person may be deemed to beneficially own the shares held by APNG 1. However, the Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. The shares subject to the stock option will vest and become exercisable in full on May 27, 2027. /s/ Vanina de Verneuil, Attorney-In-Fact 2026-05-28